Cephalon’s Paul Harmon joins IPHA board

pharmafile | January 10, 2011 | Appointment | Sales and Marketing Cephalon, IPHA, Paul Harmon, appointment, sales and marketing 

Cephalon’s Paul Harmon has been elected to the prescription medicines division strategy board of Irish pharma association IPHA, a role he will serve in for three years.

Paul joined Cephalon Pharma (Ireland) Limited in 2006 as national sales manager and was appointed as business unit director Ireland and chief representative to IPHA in 2008.

He has over 10 years experience in the pharmaceutical and biopharmaceutical industry in Ireland and internationally, having joined Pfizer Healthcare Ireland in 1999 following a stint in mental health nursing.

Related Content

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

funk

Lonza CEO to step down in 2020

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …

Latest content